DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
about
Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells.Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia.EZH2-, CHD4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients.DNA hydroxymethylation levels are altered in blood cells from Down syndrome persons enrolled in the MARK-AGE project.
P2860
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
@ast
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
@en
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
@nl
type
label
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
@ast
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
@en
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
@nl
prefLabel
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
@ast
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
@en
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
@nl
P2093
P2860
P3181
P356
P1476
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
@en
P2093
Hanae Sato
Justin C. Wheat
Keisuke Ito
Ulrich Steidl
P2860
P3181
P356
10.3389/FONC.2016.00187
P407
P577
2016-08-22T00:00:00Z